Emma TumiltyMy Comment to the FDA AdComms regarding MAPS/Lykos’ NDAI was travelling and unable to get my comment submitted for the public period but did so before the final deadline. I wanted to share it…Jun 6Jun 6
Emma TumiltyConsent and Withdrawal in Psychedelic ResearchSlides and referencesDec 8, 2022Dec 8, 2022
Emma TumiltyHealth Canada Investigation of MDMA Clinical Trials Findings — A ResponseBy the Complainers GroupJul 26, 20221Jul 26, 20221